Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission.
Saved in:
| Title: | Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission. |
|---|---|
| Authors: | Gamerith G; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria., Mildner F; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria., Merkel PA; Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Harris K; Immune Tolerance Network (ITN), Bethesda, Maryland, USA., Cooney L; Immune Tolerance Network (ITN), Bethesda, Maryland, USA., Lim N; Immune Tolerance Network (ITN), Bethesda, Maryland, USA., Spiera R; Hospital for Special Surgery, New York City, New York, USA., Seo P; Department of Internal Medicine, Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA., Langford CA; Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Hoffman GS; Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA., St Clair EW; Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA., Fervenza FC; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA., Monach P; VA Boston Healthcare System, West Roxbury, Massachusetts, USA., Ytterberg SR; Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA., Geetha D; Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA., Amann A; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria., Wolf D; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria., Specks U; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, New York, USA., Stone JH; Rheumatology Unit, Division of Rheumatology Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kronbichler A; Department of Medicine, University of Cambridge, Cambridge, UK ak2283@cam.ac.uk. |
| Source: | Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Feb; Vol. 82 (2), pp. 253-261. Date of Electronic Publication: 2022 Aug 16. |
| Publication Type: | Randomized Controlled Trial; Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35973802 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gamerith+G%22">Gamerith G</searchLink>; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Mildner+F%22">Mildner F</searchLink>; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Merkel+PA%22">Merkel PA</searchLink>; Division of Rheumatology and Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Harris+K%22">Harris K</searchLink>; Immune Tolerance Network (ITN), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Cooney+L%22">Cooney L</searchLink>; Immune Tolerance Network (ITN), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lim+N%22">Lim N</searchLink>; Immune Tolerance Network (ITN), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Spiera+R%22">Spiera R</searchLink>; Hospital for Special Surgery, New York City, New York, USA.<br /><searchLink fieldCode="AU" term="%22Seo+P%22">Seo P</searchLink>; Department of Internal Medicine, Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Langford+CA%22">Langford CA</searchLink>; Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Hoffman+GS%22">Hoffman GS</searchLink>; Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22St+Clair+EW%22">St Clair EW</searchLink>; Rheumatology, Duke University School of Medicine, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Fervenza+FC%22">Fervenza FC</searchLink>; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Monach+P%22">Monach P</searchLink>; VA Boston Healthcare System, West Roxbury, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ytterberg+SR%22">Ytterberg SR</searchLink>; Division of Rheumatology, Mayo Clinic, Rochester, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Geetha+D%22">Geetha D</searchLink>; Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Amann+A%22">Amann A</searchLink>; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Wolf+D%22">Wolf D</searchLink>; Department of Internal Medicine V, Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Specks+U%22">Specks U</searchLink>; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Stone+JH%22">Stone JH</searchLink>; Rheumatology Unit, Division of Rheumatology Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Kronbichler+A%22">Kronbichler A</searchLink>; Department of Medicine, University of Cambridge, Cambridge, UK ak2283@cam.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372355%22">Annals of the rheumatic diseases</searchLink> [Ann Rheum Dis] 2023 Feb; Vol. 82 (2), pp. 253-261. <i>Date of Electronic Publication: </i>2022 Aug 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Randomized Controlled Trial; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372355 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1468-2060 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200034967%22">00034967 </searchLink><i>NLM ISO Abbreviation: </i>Ann Rheum Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35973802 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/ard-2022-222479 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 253 Titles: – TitleFull: Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gamerith G – PersonEntity: Name: NameFull: Mildner F – PersonEntity: Name: NameFull: Merkel PA – PersonEntity: Name: NameFull: Harris K – PersonEntity: Name: NameFull: Cooney L – PersonEntity: Name: NameFull: Lim N – PersonEntity: Name: NameFull: Spiera R – PersonEntity: Name: NameFull: Seo P – PersonEntity: Name: NameFull: Langford CA – PersonEntity: Name: NameFull: Hoffman GS – PersonEntity: Name: NameFull: St Clair EW – PersonEntity: Name: NameFull: Fervenza FC – PersonEntity: Name: NameFull: Monach P – PersonEntity: Name: NameFull: Ytterberg SR – PersonEntity: Name: NameFull: Geetha D – PersonEntity: Name: NameFull: Amann A – PersonEntity: Name: NameFull: Wolf D – PersonEntity: Name: NameFull: Specks U – PersonEntity: Name: NameFull: Stone JH – PersonEntity: Name: NameFull: Kronbichler A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2023 Feb Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1468-2060 Numbering: – Type: volume Value: 82 – Type: issue Value: 2 Titles: – TitleFull: Annals of the rheumatic diseases Type: main |
| ResultId | 1 |